Approval · Notice of Compliance 2990 · 1998
AVONEX: Notice of Compliance 2990
Issued April 6, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2990
- Date
- April 6, 1998
- Company
- Biogen Canada IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Immunomodulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVONEX | 02237770 | Cancelled Post Market |
Medicinal ingredients
- INTERFERON BETA-1A 30 MCG per ML